Almujtama Alraida Medical Co. (9592.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Almujtama Alraida Medical Co. — annual and quarterly history.
| Metric (SAR Millions) | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | 2↓83.2% | 13↑220.6% | 4↓3.9% | 4 | |
| Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash & Short-Term Investments | 2↓83.2% | 13↑220.6% | 4↓3.9% | 4 | |
| Net Receivables | 34↑29.4% | 26↑89.7% | 14↓16.1% | 16 | |
| Accounts Receivable | 34↑64.3% | 20↑98.3% | 10↓26.7% | 14 | |
| Other Receivables | 0.00↓100.0% | 6↑63.4% | 3↑50.6% | 2 | |
| Inventory | 144↑0.7% | 143↑5.6% | 136↑6.1% | 128 | |
| Prepaid Assets | 7↑177.3% | 3↓60.6% | 7↑78.9% | 4 | |
| Other Current Assets | 0.75 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 188↑1.7% | 185↑15.6% | 160↑5.2% | 152 | |
| Property, Plant & Equipment | 270↑5.6% | 256↑47.9% | 173↑15.7% | 149 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 1↓12.7% | 1↓11.2% | 2↓10.1% | 2 | |
| Goodwill & Intangible Assets | 1↓12.7% | 1↓11.2% | 2↓10.1% | 2 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 271↑5.5% | 257↑47.4% | 174↑15.4% | 151 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 459↑4.0% | 442↑32.2% | 334↑10.3% | 303 | |
| Liabilities | |||||
| Total Payables | 115↑10.2% | 105↑39.2% | 75↓23.5% | 98 | |
| Accounts Payable | 115↑11.7% | 103↑41.1% | 73↓25.3% | 98 | |
| Other Payables | 0.35↓79.7% | 2↓23.9% | 2↑236.3% | 0.67 | |
| Accrued Expenses | 0.00 | 0.00 | 0.00↓100.0% | 0.07 | |
| Short-Term Debt | 31↑8.0% | 28↑39.7% | 20↓5.3% | 21 | |
| Current Lease Obligations | 31↑8.0% | 28↑39.7% | 20↓5.3% | 21 | |
| Tax Payables | 0.00↓100.0% | 2↓23.9% | 2↑236.3% | 0.67 | |
| Deferred Revenue | 0.00 | 0.00 | 0.00↓100.0% | 0.67 | |
| Other Current Liabilities | -1↓131.1% | 4↑149.9% | -8↓116.0% | 49 | |
| Total Current Liabilities | 175↑6.0% | 165↑53.3% | 108↓43.6% | 191 | |
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Lease Obligations | 140↓0.5% | 141↑36.7% | 103↑6.5% | 97 | |
| Non-Current Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 6↓1.8% | 6↑23.0% | 5↓22.6% | 7 | |
| Total Non-Current Liabilities | 146↓0.6% | 147↑36.1% | 108↑4.6% | 103 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 170↑0.9% | 169↑37.2% | 123↑4.4% | 118 | |
| Total Liabilities | 321↑2.9% | 312↑44.7% | 216↓26.7% | 295 | |
| Equity | |||||
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock | 95↑0.0% | 95↑0.0% | 95↑16864.3% | 0.56 | |
| Retained Earnings | 41↑25.8% | 32↑52.7% | 21↑166.2% | 8 | |
| Additional Paid-In Capital | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | 2↑0.0% | 2↑0.0% | 2↑1306.1% | 0.17 | |
| Other Stockholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Stockholders' Equity | 138↑6.4% | 130↑9.4% | 119↑1262.7% | 9 | |
| Total Equity | 138↑6.4% | 130↑9.4% | 119↑1262.7% | 9 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities & Equity | 459↑4.0% | 442↑32.2% | 334↑10.3% | 303 | |
| Balance Sheet Summary | |||||
| Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Debt | 170↑0.9% | 169↑37.2% | 123↑4.4% | 118 | |
| Net Debt | 168↑7.9% | 156↑31.0% | 119↑4.7% | 114 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.